Suchergebnisse - "Fan, Nanfeng"

PubPharm (17)

1

Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer : a phase Ⅱ study

enthalten in: EBioMedicine | 2024

von Yang, L. | Zhang, W. | Fan, N. | +24

2

The Expression Pattern of Ferroptosis-Related Genes in Colon Adenocarcinoma : Highly Correlated to Tumor Microenvironment Characteristics

enthalten in: Frontiers in genetics | 2022

von Liu, J. | Li, H. | Zhao, S. | +3

3

Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer

enthalten in: Frontiers in oncology | 2022

von Zhao, S. | Su, L. | Chen, Y. | +12

4

CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism

enthalten in: Experimental cell research | 2021

von Li, H. | Chen, J. | Liu, J. | +4

5

Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer : a single-arm phase II study

enthalten in: Cancer communications (London, England) | 2021

von Peng, Z. | Liu, T. | Wei, J. | +32

6

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer : a single‐arm phase II study

enthalten in: Cancer Communications | 2021

von Peng, Z. | Liu, T. | Wei, J. | +32

7

Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer : a single-arm exploratory study

enthalten in: Annals of translational medicine | 2020

von Zhao, S. | Fan, N. | Li, H. | +6

8

Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer : a randomized Phase III study

enthalten in: Future oncology (London, England) | 2018

von Li, J. | Xu, R. | Qin, S. | +16

ErratumIn: Future Oncol. 2019 Feb;15(4):451. - PMID 30672339

9

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2016

von Wang, J. | Xu, R. | Li, J. | +14

10

A phase 2 study of fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as a salvage treatment in patients with refractory or relapsed advanced gastric cancer

enthalten in: Journal of chemotherapy (Florence, Italy) | 2015

von Lin, R. | Fan, N. | Wu, G. | +6